Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Ekso Bionics | EKSO | 22. nov 2024 | 0.69 | -4.03 |
El Paso Pref | EP-C | 22. nov 2024 | 48.42 | +0.08 |
El Pollo Loco | LOCO | 22. nov 2024 | 12.30 | +1.74 |
Elanco Animal Health | ELAN | 22. nov 2024 | 13.36 | -0.30 |
Elastic | ESTC | 22. nov 2024 | 108.03 | +14.77 |
Elbit Systems | ESLT | 22. nov 2024 | 250.11 | +0.32 |
Eldorado Gold | EGO | 22. nov 2024 | 16.56 | -0.60 |
Electra Battery Materials | ELBM | 22. nov 2024 | 0.49 | -2.62 |
Electro-Sensors | ELSE | 22. nov 2024 | 4.22 | +0.68 |
electroCore | ECOR | 22. nov 2024 | 11.21 | +13.00 |
Electromed | ELMD | 22. nov 2024 | 29.79 | +6.13 |
Electronic Arts | EA | 22. nov 2024 | 166.67 | -0.77 |
Electrovaya | ELVA | 22. nov 2024 | 2.36 | +1.72 |
Eledon Pharmaceuticals | ELDN | 22. nov 2024 | 4.01 | -1.47 |
Element Solutions | ESI | 22. nov 2024 | 29.04 | +1.68 |
Elevai Labs | ELAB | 22. nov 2024 | 0.02 | -0.50 |
Elevance Health | ELV | 22. nov 2024 | 402.55 | -0.26 |
Elevation Oncology | ELEV | 22. nov 2024 | 0.60 | -0.30 |
Eli Lilly | LLY | 22. nov 2024 | 748.01 | -0.25 |
Elicio Therapeutics | ELTX | 22. nov 2024 | 4.93 | -3.71 |
Eliem Therapeutics | ELYM | 22. nov 2024 | 5.11 | 0.00 |
Ellington Financial | EFC-B | 22. nov 2024 | 23.10 | +0.04 |
Ellington Financial | EFC | 22. nov 2024 | 12.52 | +0.97 |
Ellington Financial A Pref | EFC-A | 22. nov 2024 | 25.29 | +0.06 |
Ellington Financial D Pref | EFC-D | 22. nov 2024 | 22.87 | +0.25 |
Ellington Financial E Pref | EFC-E | 22. nov 2024 | 25.45 | -0.10 |
Ellington Financial Pref | EFC-C | 22. nov 2024 | 25.25 | +0.68 |
Ellington Residential Mortgage REIT | EARN | 22. nov 2024 | 6.76 | +1.65 |
Ellomay Capital | ELLO | 22. nov 2024 | 16.02 | -3.49 |
Ellsworth Growth | ECF | 22. nov 2024 | 9.72 | -0.82 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.